In B cells, the error-prone repair of activation-induced cytidine deaminase (AID)-induced lesions in immunoglobulin variable genes cause somatic hypermutation (SHM) of antibody genes. Due to clonal selection in the germinal centers (GC) this active mutation process provides the molecular basis for antibody affinity maturation. AID deaminates cytosine (C) to create uracil (U) in DNA. Typically, the short patch base excision repair (spBER) effectively restores genomic U lesions. We here demonstrate that GC B cells actively degrade DNA polymerase β (Polβ), resulting in the inactivation of the gap-filling step of spBER. Consequently, lesions instigated by AID, and likely other base damages, are channeled towards mutagenic non-canonical mismatch repair (mncMMR), responsible for the vast majority of mutations at adenine and thymine (A:T) bases. Apparently, GC B cells prohibit faithful spBER, thereby favoring A:T mutagenesis during SHM. Lastly, our data suggest that the loss of Polβ relates to hypoxia that characterizes the GC microenvironment.
INTRODUCTION
Humoral or antibody-mediated immunity is essential in protecting the host against foreign pathogens. A key feature of B cells in the humoral immune response is their ability to undergo somatic hypermutation (SHM) and immunoglobulin (Ig) class switch recombination (CSR), yielding antibodies with consecutively greater affinity, and of different Ig isotypes (Methot and Di Noia, 2017) . These processes occur in the germinal center (GC), specialized anatomical sites that arise within B-cell follicles in the lymphoid organs upon infection or immunization. GCs contain two zones: a dark zone (DZ) and a light zone (LZ). In the DZ, large centroblasts clonally expand by rapid proliferation and undergo SHM. Subsequently, they migrate to the LZ and transit into centrocytes that are subject to clonal selection (MacLennan, 1994) . Affinity maturation is based on active mutagenesis of rearranged Ig variable V(D)J genes by SHM in centroblasts and subsequent selection of centrocyte subclones expressing higher affinity antibody variants for the cognate antigen and their differentiation into memory B cells and plasma cells (Victora et al., 2010) .
During SHM, predominantly single nucleotide substitutions are introduced in the Ig V genes at a rate of approximately 10 −3 mutations per base pair (bp) per generation (McKean et al., 1984; Rajewsky et al., 1987) . Activation-induced cytidine deaminase (AID) is highly expressed in GC B cells in the DZ and is of crucial importance for both SHM and CSR Revy et al., 2000) . AID catalyzes the deamination of cytosine (C) into uracil (U), resulting in the formation of highly mutagenic dU lesions in the DNA. Typically, base damages including deaminations are efficiently repaired in an error-free fashion by base excision repair (BER). However, in GC B cells dU lesions resulting from AID activity are not faithfully restored. Two principal scenarios may explain these mutagenic properties, (i) the active generation of AID-instigated lesions outcompetes canonical, non-mutagenic short patch BER (spBER), or (ii) spBER itself is suppressed to favor non-canonical, mutagenic repair pathways.
The preferred target of AID is the C embedded in the 'hotspot' WRCY motif (RGYW on the opposite strand; W = A/T, R = A/G, Y = C/T) (Álvarez-Prado et al., 2018; Rogozin and Kolchanov, 1992) . Processing of the dUs results in base substitutions and/or DNA double strand breaks (DSBs), which is largely determined by the ensuing DNA repair activities (Bahjat and Guikema, 2017; Peled et al., 2008; Stavnezer et al., 2008) . AID activity appears to be restricted to the G1-phase of the cell cycle (Le and Maizels, 2015; Schrader et al., 2007; Wang et al., 2017) , but dUs not repaired in the G1 phase will instruct a template T during S-phase, leading to insertion of an A on the opposite strand, resulting in C to T and G to A transitions. Alternatively, U removal by uracil-DNA-glycosylase (Ung), a component of the BER pathway, followed by replication over the apurinic/apyrimidinic (AP) site by translesion synthesis (TLS) DNA polymerases such as Rev1 results in transversions at C:G bps (Di Noia and Neuberger, 2002; Krijger et al., 2013; Rada et al., 2002) . In addition, AID-dependent cytosine deaminations lead to mutations at A:T bps during SHM, which is based on a mutagenic non-canonical type of MMR (mncMMR). Here, the the dU lesion is recognized as a U:G mismatch by MutS protein homolog 2 (Msh2) and MutS homolog 6 (Msh6) heterodimer, prompting DNA patch excision by the exonuclease 1 (Exo1). Subsequent gap-filling by the error-prone TLS DNA polymerase η (Polη) contributes to A:T mutagenesis, focused on the WA motif (Bardwell et al., 2004; Delbos et al., 2007; Martin et al., 2003; Martomo et al., 2004; Rogozin et al., 2001; Wilson et al., 2005; Zeng et al., 2001) . In addition, approximately half of the G:C transversions rely on both Ung and mncMMR (Krijger et al., 2009 (Krijger et al., , 2013 . Exo1 requires an incision for entry to initiate patch excision.
MutL-alpha (MutLα), composed of MutL homolog 1 (Mlh1) and Pms1 homolog 2 (Pms2), can nick the DNA on the 5′ side of the mismatch via Pms2 endonuclease activity, but Pms2 endonuclease-deficient mice displayed normal A:T mutagenesis (van Oers et al., 2010, 2) . However, loss of both Pms2 and Ung resulted in a 50% reduction of A:T mutations, suggesting that both Pms2 and Ung contribute to DNA incision required for Exo1 entry (Girelli Zubani et al., 2017) .
In GC B cells, the AP site endonuclease 2 (Ape2) was shown to be primarily responsible for DNA nicking activity downstream of Ung, thereby facilitating CSR and A:T mutagenesis during SHM Stavnezer et al., 2014) . AP endonuclease nicking yields a 3' hydroxyl group and a transient 5' abasic deoxyribose phosphate (dRP) moiety (Springgate and Liu, 1980) . During BER, AP sites are faithfully repaired by Polβ, inserting the correct nucleotide at the site of the nick and removing the dRP via its associated lyase activity (Matsumoto and Kim, 1995) . DNA ligase III (LigIII) along with its cofactor x-ray repair cross complementing 1 (Xrcc1) catalyzes the nick-sealing step (Caldecott et al., 1994 (Caldecott et al., , 1996 Gao et al., 2011; Simsek et al., 2011) . The exact role of Polβ in SHM remains to be established, as ex vivo analysis of B cells derived from Polβ-deficient hematopoietic stem cells (HSCs) in reconstituted mice indicated normal SHM (Esposito et al., 2000) , whereas in vitro stimulated Polβ-deficient B cells showed a small but significant increase in CSR and SHM (Wu and Stavnezer, 2007) .
Of interest, in vitro systems to study AID-instigated mutagenesis are characterized by the low frequency of A:T mutations versus in vivo B cells (approximately 0-20% versus 50-60% of all mutations, respectively) (Martin et al., 2002; Matthews et al., 2014; Xiao et al., 2007; Yoshikawa et al., 2002) . We hypothesized that this apparent discrepancy is caused by distinct DNA repair activities in vitro versus in vivo.
Herein, we show that cells cultured in vitro functionally express Polβ, whereas it is expressed at very low levels in GC B cells in vivo. We provide evidence that Polβ suppresses AID-instigated A:T mutagenesis in vitro, demonstrating that active loss of Polβ skews repair of AID-induced lesions towards mncMMR. Furthermore, our data suggest that GC hypoxia is responsible for the systemic breakdown of Polβ protein.
RESULTS AND DISCUSSION

Functional knockdown of Polb enables A:T mutagenesis in CH12-F3 cells
The mouse B lymphoma cell line CH12-F3 can be induced to express AID and undergo CSR to IgA when stimulated with anti-CD40, Interleukin-4 and Transforming growth factor β (TGFβ) (CIT) (Muramatsu et al., 1999; Nakamura et al., 1996) . In addition, these cells accrue AID-dependent point mutations in the Ig switch μ region (Sμ) upon stimulation, similar to mouse splenic B cells Schrader et al., 2003) . Strikingly, despite a high frequency of AID-dependent mutations 5' of the Sμ repetitive region, the CH12-F3 cells conspicuously lack A:T mutations for hitherto unknown reasons (Matthews et al., 2014) . We hypothesized that the late gap-filling and repair activities of Polβ and LigIII diminishes entry points for Exo1, thereby suppressing A:T mutagenesis. To address this, we used short hairpin RNA (shRNA) interference to silence Polb gene expression in CH12-F3 cells ( Fig. S1A) . Functional Polb knockdown was confirmed by demonstrating increased cellular sensitivity to the base methylating agent methylmethane sulfonate (MMS), which requires Polβ for DNA repair (Sobol et al., 1996) (Fig. S1B) . To determine the contribution of Polβ to the resolution of AID-induced lesions, genomic DNA was isolated from CH12-F3 cells after 7 days of CIT stimulation. The region 5' of the Sμ tandem repeats was PCR amplified from the total cell population and mutations were analyzed by cloning and Sanger sequencing. The overall mutation frequency did not differ significantly between wild type parental (WT) and Polb knockdown CH12-F3 cells (2.1 x10 -3 vs 2.5 x10 -3 , respectively, Table I ). We found that mutations at A:T base pairs were infrequent in the WT CH12-F3 cells ( 9 out of 59363 sequenced A:T bps were mutated), in agreement with a previous study (Matthews et al., 2014) . In contrast, Polb knockdown CH12-F3 cells showed a considerable number of A:T mutations (23 out of 57988 sequenced A:T bps were mutated. We conclude that silencing of Polb results in an increase in A:T mutagenesis in CH12-F3 cells (1.4 x10 -4 vs 3.9 x10 -4 , p = 0.018; 3-fold increase, Fig. 1 ). We did not observe any significant differences in the frequency of G:C transitions (4.2 x10 -3 vs 5.0 x10 -3 ), G:C transversions (2.7 x10 -4 vs 2.4 x10 -4 ) and AID hotspot mutations (4 x10 -3 vs 5 x10 -3 , Table I , Fig. 1 ). Based on these results we concluded that Polb deficiency does not affect Ung or TLS across AP sites in CH12-F3 cells.
Polβ prevents A:T mutagenesis in the G1-phase of the cell cycle
Previous studies indicated that mncMMR can be activated independently of DNA replication (Peña-Diaz et al., 2012; Schrader et al., 2007) . To determine whether Polβ inhibits mncMMR-mediated A:T mutations in the G1-phase of the cell cycle, we expressed AID fused to chromatin licensing and DNA replication factor 1 (Cdt1), which destabilizes protein outside of the G1-phase (Le and Maizels, 2015) . It was shown that in the Ramos B-cell line, the number of A:T mutations decreased upon transduction of the cells with AID-mCherry-Cdt1 (Le and Maizels, 2015) .
Interestingly, expression of AID in the G1-phase in CH12-F3 resulted in a much greater increase in A:T mutations in Polb knockdown cells (0.4 x 10 -4 vs 11 x 10 -4 p=0.0001; 27.5-fold increase, Fig. 1) . These data not only confirm the inhibitory effect of Polβ on the generation of A:T mutations but also shows that Polβ predominantly restricts A:T mutagenesis to the G1-phase of the cell cycle.
Polβ prevents recruitment of MMR proteins to the 5' Sμ region
The finding that silencing of Polb enabled A:T mutagenesis in CH12-F3 cells suggested that Polβ prohibits mncMMR mediated repair of AID-induced lesions. To determine whether Polb silencing affected the binding of MMR proteins to the 5' side of the Sμ region ( Fig. 2A) , we carried out chromatin immunoprecipitation (ChIP) experiments in WT and Polβ knockdown CH12-F3 cells. At the 5' Sμ region, Msh2, Msh6, and Exo1 were found enriched in Polb knockdown cells, confirming that Polβ prevents mncMMR downstream of AID-induced lesions (Fig. 2B) .
Polβ mediated inhibition of A:T mutagenesis is not restricted to B cells or Ig genes
Recently, it was shown that mncMMR is not solely active in B cells but also in other cell types (Peña-Diaz et al., 2012) . In an attempt to learn how mncMMR is regulated in non-B cells, we created Polb knockdown mouse NIH-3T3 fibroblast cells using shRNA (Fig. S1C) . The functional knockdown of Polb was confirmed by increased MMS sensitivity ( Fig. S1D) . AID fused to the estrogen receptor (AID-ER) was then overexpressed in this cell line, by which nuclear translocation of this fusion protein can be enforced by 4-hydroxy-tamoxifen (4-OHT) treatment. In addition, the retroviral overexpression construct contains a truncated nerve growth factor receptor (ΔNGFR) incapable of signaling, which allows the identification and sorting of transduced cells by staining with an anti-NGFR monoclonal antibody. In order to monitor AID activity we also transduced the cells with a fluorescent reporter plasmid Interestingly, in contrast to B cells we found that Polb knockdown also significantly increased the total mutation frequency (2.1 x10 -4 vs 8.4 x10 -4 , p=0.0001) and the mutation frequency in C or G in AID hotspots (WRCY/RGYW/WRC/GYW) (1x10 -4 vs 5.3 x10 -4 , p= 0.0001, Table II ). The difference between CH12-F3 and NIH-3T3 cells could be due to the overexpression of AID in the latter, and/or undetermined cell type-specific characteristics.
Interestingly, Polb knockdown resulted in a significant increase in the frequency of G:C transitions (2x10 -4 vs 5.5 x10 -4 , p=0.004) and G:C transversions (0.5x10 -4 vs 5.3x10 -4 , p=0.0001, Fig. 3) . These data suggest that Polβ suppressed the accumulation of G:C transitions and transversions in these cells, which again confirms the faithful repair activity of this polymerase.
Previously, it was demonstrated that C to G and G to C transversions can be generated by Rev1 and Polη downstream of Ung and Msh2 (Ung+Msh2 hybrid pathway) (Kano et al., 2012; Krijger et al., 2013) . Interestingly, C to G and G to C transversions were significantly increased in Polb knockdown cells (0 vs 3.0 x10 -4 , p=0.0001), perhaps by preventing the formation of Msh2/6 and Exo1-dependent gaps, which are required for these transversions by Rev1 and Polη downstream of the Ung+Msh2 hybrid pathway.
In the study by Pérez-Durán et al. it was shown that overexpression of AID leads to an increase in the total mutation frequency and also the mutation frequency at AID hotspots (Pérez-Durán et al., 2012) . We have shown that ablation of Polβ exaggerated this effect even further, which again confirms the general inhibitory effect of Polβ on AID-induced mutagenesis.
Similar to B cells we have restricted the expression of AID to G1-phase of the cell cycle using AID-mCherry-Cdt1 plasmid overexpression. The total mutation frequency and the frequency of A:T mutations did not differ significantly in WT NIH-3T3 cells expressing AID-ER versus AID-Cdt1. However, A:T mutations were increased more prominently in Polb knockdown cells compared to WT cells when AID-Cdt1 was expressed (from 0.6 x10 -4 to 7.9 x10 -4 ; 13.2-fold increased; WT vs
Polb knockdown respectively) compared to cells expressing AID-ER (from 1.4 x10 -4 to 4.4 x10 -4 ; 3.1-fold increase). We found that expression of AID-Cdt1 did not further increase the total mutation frequency (Fig. 3) . These results underscore that the Polβ-mediated inhibition of A:T mutagenesis in the G1-phase is not restricted to B cells but is also active in other cell types.
Expression of Polβ in the Germinal Center
Strikingly, several in vitro systems for AID-induced mutagenesis show a relative underrepresentation of A:T mutations versus in vivo human or mouse GC B cells (~0-20% versus 50-60% of all mutations, respectively) (Martin et al., 2002; Matthews et al., 2014; Xiao et al., 2007; Yoshikawa et al., 2002) . Based on our findings, we hypothesized that this discrepancy could be due to the difference in the regulation of Polβ under in vitro versus in vivo conditions. Therefore, we sought to determine the expression of Polβ in the GC in tissue sections of human tonsil, reactive lymph node and Peyer's patches. Sections of human testis were used as a positive control for Polβ staining. Even though that nuclear staining of Polβ was observed in testis sections ( Fig. S3A) , we barely detected any Polβ expression in the GCs in tonsil tissue ( Fig. 4A) , reactive lymph node (Fig. S3B) and Peyer's patches ( Fig. S3C) by immunohistochemistry. Despite low expression of Polβ in the GC, we observed sporadic scattered cells with high levels of nuclear Polβ within the GC. To determine the origin of these cells we have conducted double staining for Polβ and T cells (CD3), which clearly indicated that follicular T cells are the source of Polβ expression in the GC (Fig. 4B) . Immunofluorescence staining of Polβ confirmed the low expression in the DZ and LZ of GC as demarcated by the Ki67 proliferation marker ( Fig. 4C) .
We compared the mRNA expression of POLB in sorted human naïve B cells, centroblasts, centrocytes, memory B cells and bone marrow plasma cells by analysis of a previously published gene expression profiling data set (Kassambara et al., 2015) . Expression of AICDA was increased in the centroblasts confirming the sorting strategy and purity, whereas POLB mRNA was not significantly different, suggesting that Polβ expression is post-transcriptionally regulated in GC B cells ( Fig. 4D ). Of interest, it was recently shown that the GC is a hypoxic environment (Abbott et al., 2016; Cho et al., 2016) . Furthermore, in several cancer cell lines it was demonstrated that hypoxia diminished BER activity by changing the expression of several BER proteins (Chan et al., 2014) . This prompted us to assess the effect of Peyer's patches (Schrader et al., 2013) , but this may be related to the exposure of cells to normoxic conditions during the purification of these cells.
In summary, why in GC B cells AID-instigated dU lesions are not restored faithfully was not understood. We now demonstrate that spBER itself is generally suppressed by Polβ degradation. In this way, AID-instigated lesions are directed towards mncMMR and long patch BER (lpBER), both of which contribute to the generation of A:T mutations (Krijger et al., 2009) . Ung deficiency had a limited effect on A:T mutagenesis (~10% reduction) (Rada et al., 2002) , whereas Msh2 or Msh6 deficiency resulted in ~50-90% reduction of mutations at A:T bps (Rada et al., 1998; Shen et al., 2006) . Interestingly, combined deficiency of Ung/Msh2 or Ung/Msh6 resulted in the complete ablation of A:T mutagenesis (Rada et al., 2004; Shen et al., 2006) , arguing that lpBER and mncMMR contribute to A:T mutagenesis, and in line with effective recruitment of error-prone TLS polymerases, require PCNA-Ub and
Polη (Krijger et al., 2009; Langerak et al., 2007) .
The relative loss of Polβ in GC B cells in vivo in part explains how these pathways collaborate for the induction of A:T mutations, while at the same time competing for the U:G lesions. We propose that the processive nature of AID (Pham et al., 2003) 
Materials and methods
Cell culture
Mouse CH12 Cytotoxicity studies by growth inhibition assay CH12-F3 sells were seeded (20x10 4 per well) in 24 well plate in 1ml medium in triplicate without selection antibiotics. The next day, cells were treated for 1 h with a range of concentrations of the DNA methylating agent methyl methanesulfonate (MMS) (Sigma-Aldrich), and subsequently cultured for an additional 48 h. Cell death was assessed by 7-aminoactinomycin D (7-AAD, Affymetrix eBioscience, San Diego, CA) staining and flow-cytometry (FACSCantoII™, BD Biosciences). The percentage of dead cells was normalized to the untreated condition. For the NIH-3T3 cell line, cells were exposed to MMS for 24 h. Viability was assessed using the MTT (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide tetrazolium; Sigma Aldrich) assay, data was acquired using a CLARIOstar® Plus plate reader (Isogen Life
Science, De Meern, The Netherlands). Data was normalized to the untreated condition.
Chromatin immunoprecipitation
Protein-DNA binding was studied using the MAGnify Chromatin Immunoprecipitation system (Life Technologies) according to the manufacturer's protocol. In brief, 10x10 6 cells were used for each IP, which were performed in triplicate for each condition.
The cells were fixed in 1% formaldehyde for 5 minutes at 37°C and quenched for 10 Immunofluorescent images were captured using a Leica DM5500B fluorescence microscope and the Leica LAS X software suite (Leica, Wetzlar, Germany).
mOrange STOP amplification and mutation analysis
For analysis of mutations at the mOrange STOP transgene, co-transduced NIH-3T3 cells were cultured for 11 days in 6 separate wells in the presence of 1μM 4-OHT.
Cells were harvested, pooled and GFP+ and mOrange+ cells were sorted by flow cytometry. DNA was extracted using QIAamp DNA mini kit (Qiagen, Hilden, Germany) and mOrange STOP was amplified using the following primers:
(forward) 5′-AATAACATGGCCATCATCAAGGA-3′
(reverse) 5′-ACGTAGCGGCCCTCGAGTCTCTC-3′
using Phusion High-Fidelity DNA Polymerase kit (Thermo Fisher Scientific) in five independent 25 µl PCR reactions, under the following conditions: 98°C for 30s, followed by 35 cycles at 98°C for 10 s, 65°C for 30s, and 72°C for 45s.
For Sanger sequencing, PCR reactions were pooled and products were cloned using the Zero Blunt PCR cloning kit (Invitrogen) and plasmids from individual colonies were sequenced using M13 universal primers (forward) 5'-GTAAAACGACGGCCAG-3' and (reverse) 5'-CAGGAAACAGCTATGAC-3'. Sequence analysis was performed using Codon Code Aligner software (Codon Code Corp., Centerville, MA).
5'Sμ amplification and mutation analysis
For mutation analysis at the Sμ region, CH12-F3 cells were stimulated with 1 μg/ml anti-CD40 antibody (HM40-3, eBioscience), 5 ng/ml mouse IL-4 (ProSpec), and 0.5 ng/ml mouse TGF-β1 (ProSpec), and cells were grown for 7 days in 6 separate wells.
DNA was extracted and the 5'Sμ fragment was PCR amplified using the primers that were reported previously (Matthews et al., 2014) . 50ng of DNA was amplified in five independent PCR amplification reactions, which were pooled and sequenced, and analyzed as described for the mOrange STOP gene. 
